{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:55:12Z","timestamp":1788411312863,"version":"build-2803163510"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Gender-affirming medical therapy (GAMT), including puberty blockers (PB) and gender-affirming hormone therapy (GAHT), is part of the transition for many transgender and nonbinary (TGNB) individuals; however, there have been few studies investigating sexual function and desire during GAMT, and no reports on individuals who received PB.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>We aimed to qualitatively evaluate the sexual experience of TGNB individuals during GAMT and identify significant and consistent themes that arose from our analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed an Institutional Review Board-approved two-institutional study. Our study group (n\u2009=\u200963) included individuals who had received or were receiving puberty blockers (GnRHa) and\/or GAHT (estrogen or testosterone) at the time of enrollment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>The enrolled subjects were interviewed using an open-ended topic-based guide, and qualitative analysis was performed by hand coding the interview transcripts using Constructivist Grounded Theory qualitative methods until thematic saturation was reached.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 63 TGNB subjects (33 transgender women, 20 transgender men, 10 non-binary, or another gender identity), aged 18-25\u00a0years, were interviewed about the effect of GAMT on their sexual function and desire. Our analysis uncovered several themes that were consistent among subjects from different subgroups. Half the participants reported feeling no regrets regarding GAMT therapy, and the other half reported that they wished they had started GAMT sooner. Two notable themes were identified: many subjects reported \u201cless dysphoria\u201d as a positive change in sexual desire, and others reported more enjoyable sexual experiences since being on GAMT. The subgroup of subjects with a history of GnRHa use did not differ in their experiences and responses from the subgroup on GAHT alone, which indicated no negative effect of GnRHa on sexual function.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Implications<\/jats:title>\n                  <jats:p>Our results illuminate the need for providers to discuss the potential impacts of GAMT on sexual function and desire with transgender and nonbinary patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths &amp; Limitations<\/jats:title>\n                  <jats:p>An important strength of this study is the open-ended interview design. This design allowed subjects to speak freely and openly about their experience. One limitation is a relatively small sample size, particularly of the puberty blocker (GnRHa) subgroup. A more robust sample is needed to further investigate the effect of GAMT on sexual function and desire in TGNB individuals, specifically those receiving GnRHa.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Themes were similar for all subjects; however, the most prominent theme among our subjects was that the positive changes in sexual function and desire outweighed any negative changes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jsxmed\/qdaf061","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T16:39:06Z","timestamp":1744043946000},"page":"945-950","source":"Crossref","is-referenced-by-count":9,"title":["Experience with gender affirming hormones and puberty blockers (gonadotropin releasing hormone agonist): a qualitative analysis of sexual function"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0870-4356","authenticated-orcid":false,"given":"Jamie L","family":"Finegan","sequence":"first","affiliation":[{"name":"Department of Urology, University of California, San Diego Health , San Diego, CA 92103 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Marinkovic","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California, San Diego Health , San Diego, CA 92103 ,","place":["United States"]},{"name":"Center for Gender Affirming Care, Rady Children\u2019s Hospital San Diego , San Diego, CA 92123,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Okamuro","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California, San Diego Health , San Diego, CA 92103 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron S","family":"Newfield","sequence":"additional","affiliation":[{"name":"Center for Gender Affirming Care, Rady Children\u2019s Hospital San Diego , San Diego, CA 92123,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer T","family":"Anger","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California, San Diego Health , San Diego, CA 92103 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"issue":"Suppl 1","key":"2025051303323682400_ref1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of Care for the Health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"issue":"11","key":"2025051303323682400_ref2","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025051303323682400_ref3","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jsxm.2020.01.012","article-title":"European Society for Sexual Medicine position statement: assessment and hormonal Management in Adolescent and Adult Trans People, with attention for sexual function and satisfaction","volume":"17","author":"T'Sjoen","year":"2020","journal-title":"J Sex Med"},{"key":"2025051303323682400_ref4","volume-title":"Validation of the Multilayered Gender Identity Questionnaires","author":"Eiseman","year":"2017"},{"issue":"8","key":"2025051303323682400_ref5","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00192-024-05857-6","article-title":"Evaluation of sexual function of transgender individuals","volume":"35","author":"Barcelos","year":"2024","journal-title":"Int Urogynecol J"},{"issue":"4","key":"2025051303323682400_ref6","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jsxm.2019.12.020","article-title":"Sexual desire changes in transgender individuals upon initiation of hormone treatment: results from the longitudinal European network for the investigation of gender incongruence","volume":"17","author":"Defreyne","year":"2020","journal-title":"J Sex Med"},{"issue":"11","key":"2025051303323682400_ref7","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1111\/j.1743-6109.2009.01370.x","article-title":"Sexual functioning in transsexuals following hormone therapy and genital surgery: a review","volume":"6","author":"Klein","year":"2009","journal-title":"J Sex Med"},{"issue":"4","key":"2025051303323682400_ref8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S2213-8587(16)00036-X","article-title":"Testosterone therapy for transgender men","volume":"5","author":"Irwig","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2025051303323682400_ref9","doi-asserted-by":"publisher","first-page":"669.e1","DOI":"10.1016\/j.ajog.2023.08.035","article-title":"Testosterone use and sexual function among transgender men and gender diverse people assigned female at birth","volume":"229","author":"Tordoff","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2025051303323682400_ref10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1743-6109.2004.10112.x","article-title":"Endocrine aspects of female sexual dysfunction","volume":"1","author":"Davis","year":"2004","journal-title":"J Sex Med"},{"issue":"2","key":"2025051303323682400_ref11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41585-018-0108-8","article-title":"Supporting sexuality and improving sexual function in transgender persons","volume":"16","author":"Holmberg","year":"2019","journal-title":"Nat Rev Urol"},{"key":"2025051303323682400_ref12","first-page":"1","volume-title":"Constructing Grounded Theory: A Practical Guide through Qualitative Analysis","author":"Charmaz","year":"2008"},{"issue":"6","key":"2025051303323682400_ref13","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jsxm.2022.03.214","article-title":"Avoiding assumptions: sexual function in transgender and non-binary individuals","volume":"19","author":"Whitney","year":"2022","journal-title":"J Sex Med"},{"issue":"3","key":"2025051303323682400_ref14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/0092623X.2023.2300828","article-title":"Trans, gender non-conforming and non-binary individuals' perspectives on experienced sexuality during medical transition","volume":"50","author":"Ross","year":"2024","journal-title":"J Sex Marital Ther"},{"issue":"3","key":"2025051303323682400_ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36484","article-title":"Gender-affirming hormone therapy: physical and sociopsychological effects, impact, and satisfaction","volume":"15","author":"Santos","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"2025051303323682400_ref16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1080\/0092623X.2017.1405303","article-title":"Sexual experiences in transgender people: the role of desire for gender-confirming interventions, psychological well-being, and body satisfaction","volume":"44","author":"Nikkelen","year":"2018","journal-title":"J Sex Marital Ther"},{"issue":"4","key":"2025051303323682400_ref17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ucl.2021.06.004","article-title":"Sexual dysfunction in transgender people: a systematic review","volume":"48","author":"Mattawanon","year":"2021","journal-title":"Urol Clin North Am"},{"issue":"12","key":"2025051303323682400_ref18","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.jsxm.2019.09.003","article-title":"Prevalence of sexual dysfunctions in transgender persons: results from the ENIGI follow-up study","volume":"16","author":"Kerckhof","year":"2019","journal-title":"J Sex Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/22\/5\/945\/62883434\/qdaf061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/22\/5\/945\/62883434\/qdaf061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:32:46Z","timestamp":1747121566000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/22\/5\/945\/8107664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,4,7]]},"published-print":{"date-parts":[[2025,5,10]]}},"URL":"https:\/\/doi.org\/10.1093\/jsxmed\/qdaf061","relation":{},"ISSN":["1743-6095","1743-6109"],"issn-type":[{"value":"1743-6095","type":"print"},{"value":"1743-6109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,4,7]]}}}